<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">The Clinician</journal-id><journal-title-group><journal-title xml:lang="en">The Clinician</journal-title><trans-title-group xml:lang="ru"><trans-title>Клиницист</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8338</issn><issn publication-format="electronic">2412-8775</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">196</article-id><article-id pub-id-type="doi">10.17650/1818-8338-2015-9-2-53-58</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>PHARMACOTHERAPY</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ФАРМАКОТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">USE OF THREE-COMPONENT LEVODOPA (LEVODOPA/CARBIDOPA/ENTACAPONE) TO CORRECT NOCTURNAL SYMPTOMS OF PARKINSON,S DISEASE</article-title><trans-title-group xml:lang="ru"><trans-title>ПРИМЕНЕНИЕ ТРЕХКОМПОНЕНТНОЙ ФОРМЫ ЛЕВОДОПЫ (ЛЕВОДОПА/КАРБИДОПА/ ЭНТАКАПОН) ДЛЯ КОРРЕКЦИИ НОЧНЫХ СИМПТОМОВ БОЛЕЗНИ ПАРКИНСОНА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Kulua</surname><given-names>T. K.</given-names></name><name xml:lang="ru"><surname>Кулуа</surname><given-names>Т. К.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Fedorova</surname><given-names>N. V.</given-names></name><name xml:lang="ru"><surname>Фёдорова</surname><given-names>Н. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>natalia.fedorova@list.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Department of Neurology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Кафедра неврологии ГБОУ ДПО «Российская медицинская академия последипломного образования» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">2/1 Barrikadnaya St., Moscow, 125993, Russia</institution></aff><aff><institution xml:lang="ru">Россия, 125993, Москва, ул. Баррикадная, 2/1</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Center of Extrapyramidal Diseases, Ministry of Health of Russia</institution></aff><aff><institution xml:lang="ru">Центр экстрапирамидных заболеваний нервной системы Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">5 2nd Botkinsky Proezd, Moscow, 125101, Russia</institution></aff><aff><institution xml:lang="ru">Россия, 125101, Москва, 2-й Боткинский проезд, 5.</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2015-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2015</year></pub-date><volume>9</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>53</fpage><lpage>58</lpage><history><date date-type="received" iso-8601-date="2015-08-13"><day>13</day><month>08</month><year>2015</year></date><date date-type="accepted" iso-8601-date="2015-08-13"><day>13</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2015, Kulua T.K., Fedorova N.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2015, Кулуа Т.К., Фёдорова Н.В.</copyright-statement><copyright-year>2015</copyright-year><copyright-holder xml:lang="en">Kulua T.K., Fedorova N.V.</copyright-holder><copyright-holder xml:lang="ru">Кулуа Т.К., Фёдорова Н.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://klinitsist.abvpress.ru/Klin/article/view/196">https://klinitsist.abvpress.ru/Klin/article/view/196</self-uri><abstract xml:lang="en"><p/></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>Parkinson</kwd><kwd>s disease</kwd><kwd>nocturnal symptoms</kwd><kwd>sleep disorders</kwd><kwd>motor fluctuations</kwd><kwd>drug-induced nocturnal dyskinesias</kwd><kwd>nocturnal akinesia</kwd><kwd>restless legs syndrome</kwd><kwd>cramps</kwd><kwd>levodopa/carbidopa/entacapone</kwd><kwd>Stalevo</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>болезнь Паркинсона, ночной симптом, нарушение сна, моторная флюктуация, ночная лекарственная дискинезия, ночная акинезия, синдром беспокойных ног, крампи, леводопа/карбидопа/энтакапон, Сталево</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson,s disease. Clin Neuropharmacol 1988;11(6):512–9.</mixed-citation><mixed-citation xml:lang="ru">Lees A.J., Blackburn N.A., Campbell V.L. The nighttime problems of Parkinson,s disease. Clin Neuropharmacol 1988;11(6):512–9.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Stocchi F., Brusa L., Vacca L. et al. Sleep disturbances in Parkinson’s disease. Eur J Neurol 2000;7(Suppl 4):21–5.</mixed-citation><mixed-citation xml:lang="ru">Stocchi F., Brusa L., Vacca L. et al. Sleep disturbances in Parkinson’s disease. Eur J Neurol 2000;7(Suppl 4):21–5.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Chaudhuri K.R. Nocturnal symptom complex in PD and its management. Neurology 2003;61(6 Suppl 3):S17–23.</mixed-citation><mixed-citation xml:lang="ru">Chaudhuri K.R. Nocturnal symptom complex in PD and its management. Neurology 2003;61(6 Suppl 3):S17–23.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Chaudhuri K.R., Pal S., Bridgman K., Trenkwalder C. Achieving 24-hour control of Parkinson,s disease symptoms; use of objective measures to improve nocturnal disability. Eur Neurol 2001;46(Suppl 1):3–10.</mixed-citation><mixed-citation xml:lang="ru">Chaudhuri K.R., Pal S., Bridgman K., Trenkwalder C. Achieving 24-hour control of Parkinson,s disease symptoms; use of objective measures to improve nocturnal disability. Eur Neurol 2001;46(Suppl 1):3–10.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Suzuki K., Miyamoto M., Miyamoto T. et al. Sleep disturbances associated with Parkinson,s disease. Parkinsons Dis. 2011.</mixed-citation><mixed-citation xml:lang="ru">Suzuki K., Miyamoto M., Miyamoto T. et al. Sleep disturbances associated with Parkinson,s disease. Parkinsons Dis. 2011.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Ferreira J.J., Katzenschlager R., Bloem B.R. et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson,s disease. Eur J Neurol 2013;20(1):5–15.</mixed-citation><mixed-citation xml:lang="ru">Ferreira J.J., Katzenschlager R., Bloem B.R. et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson,s disease. Eur J Neurol 2013;20(1):5–15.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Chaudhury K.R., Pal S., DiMarco A. et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson,s disease. J Neurol Neurosurg Psychiatry 2002;73(6):629–35.</mixed-citation><mixed-citation xml:lang="ru">Chaudhury K.R., Pal S., DiMarco A. et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson,s disease. J Neurol Neurosurg Psychiatry 2002;73(6):629–35.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Johns M.W. A new method for measuring daytime sleepiness: the Ep – worth sleepiness scale. Sleep 1991;14(6):540–5.</mixed-citation><mixed-citation xml:lang="ru">Johns M.W. A new method for measuring daytime sleepiness: the Ep – worth sleepiness scale. Sleep 1991;14(6):540–5.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Kuoppamaki M., Korpela K., Marttila R. et al. Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/ carbidopa when administered fouror five times daily Eur J Clin Pharmacol 2009;65(5):443–55.</mixed-citation><mixed-citation xml:lang="ru">Kuoppamaki M., Korpela K., Marttila R. et al. Comparison of pharmacokinetic profile of levodopa throughout the day between levodopa/carbidopa/entacapone and levodopa/ carbidopa when administered fouror five times daily Eur J Clin Pharmacol 2009;65(5):443–55.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10. Фёдорова Н.В., Левин О.С., Смоленцева И.Г., Кулуа Т.К. Препарат леводопы нового поколения Сталево (леводопа/карбидопа/энтакапон) в лечении болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова 2006;106(9):39–46. [Fedorova N.V., Levin O.S., Smolentseva I.G., Kulua T.K. Stalevo (levodopa/carbidopa/entacapone) – levodopa drug of new generation for management of Parkinson disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2006;106(9):39–46. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Фёдорова Н.В., Левин О.С., Смоленцева И.Г., Кулуа Т.К. Препарат леводопы нового поколения Сталево (леводопа/карбидопа/энтакапон) в лечении болезни Паркинсона. Журнал неврологии и психиатрии им. С.С. Корсакова 2006;106(9):39–46. [Fedorova N.V., Levin O.S., Smolentseva I.G., Kulua T.K. Stalevo (levodopa/carbidopa/entacapone) – levodopa drug of new generation for management of Parkinson disease. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2006;106(9):39–46. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11. Кулуа Т.К., Фёдорова Н.В., Поповкина О.А. Ночные моторные симптомы болезни Паркинсона и их коррекция трехкомпонентным препаратом леводопа/карбидоа/энтакапон. Журнал неврологии и психиатрии им. С.С. Корсакова 2011;111(9–2):45–50. [Kulua T.K., Fedorova N.V., Popovkina O.A. Night motor symptoms of Pasrkinson disease and their correction by three-component drug of levodopa/carbidopa/entacapone. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2011;111(9–2):45–50. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Кулуа Т.К., Фёдорова Н.В., Поповкина О.А. Ночные моторные симптомы болезни Паркинсона и их коррекция трехкомпонентным препаратом леводопа/карбидоа/энтакапон. Журнал неврологии и психиатрии им. С.С. Корсакова 2011;111(9–2):45–50. [Kulua T.K., Fedorova N.V., Popovkina O.A. Night motor symptoms of Pasrkinson disease and their correction by three-component drug of levodopa/carbidopa/entacapone. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2011;111(9–2):45–50. (In Russ.)].</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12. Кулуа Т.К., Фёдорова Н.В. Ночные симптомы болезни Паркинсона и подходы к их коррекции. Журнал неврологии и психиатрии им. С.С. Корсакова 2013;113(12): 62–6. [Kulua T.K., Fedorova N.V. Night symptoms of Parkinson disease and approaches to their correction. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2013;113(12):62–6. (In Russ.)].</mixed-citation><mixed-citation xml:lang="ru">Кулуа Т.К., Фёдорова Н.В. Ночные симптомы болезни Паркинсона и подходы к их коррекции. Журнал неврологии и психиатрии им. С.С. Корсакова 2013;113(12): 62–6. [Kulua T.K., Fedorova N.V. Night symptoms of Parkinson disease and approaches to their correction. Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova = S.S. Korsakov Journal of Neurology and Psychiatry 2013;113(12):62–6. (In Russ.)].</mixed-citation></citation-alternatives></ref></ref-list></back></article>
